Skip to content
646 269 0773|alita@globalbioethics.org
facebooktwitterlinkedin
Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo
  • Home
  • About
  • Staff
    • Founders
    • Board of Directors
    • Advisory Board
    • Visiting Scholars
    • Student Interns
    • Volunteers
  • Events
  • Resources
    • COVID-19
  • Internships
  • Contact
  • Donate
Previous Next
  • View Larger Image Oxycodone

America’s Opioid Epidemic and its Impact on Organ Donations

By Aidan Appleby

With 121,000 people in the U.S. actively awaiting organs, an increase in the number of organ donations could not have come at a better time. Unfortunately, the reason more organs are becoming available is because of a drug epidemic. According to the United Network of Organ Sharing (UNOS), the number of deaths from drug overdose rose by 270% between 2006 and 2015. This means that more organ donors have died due to drug overdose, thus increasing the number of organs available for transplant. Alexandra Glazier, president of the New England Organ Bank, called this a “silver lining to what is absolutely a tragedy.” It is now estimated that one out of every eleven organ donors died as a result of a drug overdose. It is believed that this increase is due, in large part, to prescription opioids and heroin.

One concern people express is that transplanting organs from drug addicts could be dangerous. However, this is rarely the case. Drug overdose victims are labeled as “high-risk donors,” so they are tested more carefully. They are subjected to many tests, including tests for HIV, Hepatitis B, and Hepatitis C. The patient is far less likely to be harmed by the “high-risk” donation than by the surgery itself. Furthermore, David Klassen, chief medical officer for the United Network for Organ Sharing, claims that most victims of drug overdose are young people and that, while long-term drug use can indeed damage organs, these young victims often have very healthy organs.

The patients are also required to give consent when they are offered a high-risk organ, and those who have other options (like those who are waiting for a kidney, where dialysis can be used) can absolutely refuse the transplant. However, Klassen points out that patients who are waiting for livers or hearts may not get another donation in time.

Read the full article here.

Other Posts

UN political affairs chief warns of ‘utter devastation’ facing Ukraine cities by Russian forcesAdmin2022-03-14T17:36:12+00:00

Admin2022-03-14T17:36:12+00:00March 14th, 2022|Comments Off on UN political affairs chief warns of ‘utter devastation’ facing Ukraine cities by Russian forces

Health care under siege: Voices from the war in UkraineAdmin2022-03-14T17:33:40+00:00

Admin2022-03-14T17:33:40+00:00March 14th, 2022|Comments Off on Health care under siege: Voices from the war in Ukraine

Invasion of Ukraine: Neighbours struggle with refugee influx; UN expresses ‘horror’ at Mariupol hospital attackAdmin2022-03-14T17:27:03+00:00

Admin2022-03-14T17:27:03+00:00March 14th, 2022|Comments Off on Invasion of Ukraine: Neighbours struggle with refugee influx; UN expresses ‘horror’ at Mariupol hospital attack

Russian doctors plead for end to warAdmin2022-03-14T04:17:28+00:00

Admin2022-03-14T04:17:28+00:00March 14th, 2022|Comments Off on Russian doctors plead for end to war

By Admin@gbi|2020-04-09T23:47:58+00:00May 18th, 2016|News-Articles|0 Comments

Share This Story, Choose Your Platform!

facebooktwitterlinkedinreddittumblrpinterestvkEmail

About the Author: Admin@gbi

Avatar

Related Posts

  • Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024
    Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024
    Gallery

    Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024

  • AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics
    AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics
    Gallery

    AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics

  • A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD
    A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD
    Gallery

    A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD

  • Jonathan D. Moreno Ph.D. Keynote Speaker
    Jonathan D. Moreno Ph.D. Keynote Speaker
    Gallery

    Jonathan D. Moreno Ph.D. Keynote Speaker

  • Jeanne F. Loring Ph.D. Keynote Speaker
    Jeanne F. Loring Ph.D. Keynote Speaker
    Gallery

    Jeanne F. Loring Ph.D. Keynote Speaker

Recent Tweets

Tweets by GBISummerSchool

Find us on Facebook

Copyright 2012 - 2020 Global Bioethics | All Rights Reserved | Powered by Global Innovation Consortium
facebooktwitterlinkedin
Toggle Sliding Bar Area